The cost-constrained healthcare environment continues to demand that pharma demonstrates convincing incremental brand value. At the same time the hurdles to gaining reimbursement or coverage and ...
1 While many organisations default to passive management of these brands, forward-thinking companies are adopting systematic frameworks to maximise the value of their established brands portfolio.